Your science and technology news reporter from Ohio

Provided by AGP

Got News to Share?

Technology Journal of Ohio: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal of Ohio.

Press releases published on April 22, 2026

StreamDSP sFPDP Gen 3 (VITA 17.3) v4.2 IP Core Now Available
Delta Media Group Launches Delta Create Studio with AI-Powered Content Creation including Canva Inside DeltaNET
Night Dispatcher Turnover Is Costing Trucking Companies More Than They Realize
Insider Perks Launches the Outdoor Hospitality Pricing Index, the Industry's First Monthly Pricing Benchmark
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
The Elmet Group Co. Announces Pricing of Upsized Initial Public Offering
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
Communiqué de presse :  Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée
 nCino Announces Nick Edwards as Managing Director for APAC
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
Kneat to Announce 2026 First-Quarter Financial Results May 13, 2026
George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage
GigaCloud Technology Inc Announces Planned Retirement of Head of Brand Center
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K Filing
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Altimmune Announces Proposed Underwritten Public Offering of Securities
Alzai Health Corp. Files Final Prospectus in Connection With Initial Public Offering
IBEX Limited to Announce Third Quarter 2026 Financial Results on May 6, 2026
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents

Share us

on your social networks:

Sign up for:

Technology Journal of Ohio

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.